(Jerusalem Post) Maayan Jaffe-Hoffman - 77% of patients suffering from stage IV metastatic pancreatic cancer and treated with a protocol developed by Israeli biopharmaceutical company BioLineRx were able to get their disease under control, according to results of an ongoing study.
2019-12-20 00:00:00Full ArticleBACK Visit the Daily Alert Archive